KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Acquisitions & Divestments (2016 - 2023)

Amgen has reported Change in Acquisitions & Divestments over the past 15 years, most recently at -$575.0 million for Q3 2023.

  • For Q3 2023, Change in Acquisitions & Divestments fell 1123.4% year-over-year to -$575.0 million; the TTM value through Jun 2024 reached -$575.0 million, down 126.16%, while the annual FY2023 figure was $550.0 million, 50.89% down from the prior year.
  • Change in Acquisitions & Divestments for Q3 2023 was -$575.0 million at Amgen, down from $1.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $18.2 billion in Q3 2019 and troughed at -$9.6 billion in Q4 2019.
  • A 5-year average of $1.3 billion and a median of $904.0 million in 2021 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 1959.2% in 2020 and fell as far as 2639.13% in 2020.
  • Year by year, Change in Acquisitions & Divestments stood at -$9.6 billion in 2019, then skyrocketed by 124.58% to $2.4 billion in 2020, then crashed by 61.68% to $904.0 million in 2021, then grew by 23.89% to $1.1 billion in 2022, then tumbled by 151.34% to -$575.0 million in 2023.
  • Business Quant data shows Change in Acquisitions & Divestments for AMGN at -$575.0 million in Q3 2023, $1.0 million in Q2 2023, and $1.1 billion in Q1 2023.